Related Experiment Video
Updated: May 17, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a
Cynthia Freiberg1, Arad Dotan2,3, Dana Arnheim2,3
1Maccabi Healthcare Services, Tel Aviv, Israel. cynthia.marciano@mail.huji.ac.il.
Insights
Autoimmune disease incidence in children remained stable during COVID-19. However, COVID-19 vaccination was associated with a higher risk of developing autoimmune diseases, warranting further pediatric research.
Area of Science:
- Pediatric autoimmune diseases
- Epidemiology
- Vaccine safety
Background:
- Reports suggested increased autoimmune diseases (AID) in adults during COVID-19.
- This study investigated pediatric AID incidence pre- and during the pandemic.
- Potential links to SARS-CoV-2 vaccination were explored.
Purpose of the Study:
- To determine pediatric autoimmune disease incidence trends before and during the COVID-19 pandemic.
- To investigate the association between COVID-19 vaccination and new-onset autoimmune diseases in children.
Main Methods:
- Analysis of 493,705 anonymized medical records from Maccabi Healthcare Services (2014-2022).
- Study period divided into pre-pandemic (2014-2019) and pandemic (2020-2022) phases.
- Logistic regression and hazard ratios used to assess disease incidence and risk factors.
Main Results:
- Overall pediatric autoimmune disease incidence remained stable (0.9%-1.0%) across pre-pandemic and pandemic phases (p=0.13).
- COVID-19 diagnosis was not significantly associated with increased autoimmune disease risk (HR 1.092, p=0.491).
- Receiving at least one COVID-19 vaccine was linked to a higher risk of autoimmune diseases (HR 1.2323, p=0.0033).
Conclusions:
- Pediatric autoimmune disease incidence was stable during the COVID-19 pandemic.
- A potential association exists between COVID-19 vaccination and increased autoimmune disease risk in children.
- Further research is needed to understand the long-term effects of COVID-19 vaccination on pediatric autoimmune disease development.
Background:
During the COVID-19 pandemic there were reports of an increased association between COVID 19 and various autoimmune diseases (AID) in adults. This study aims to investigate the incidence of AIDs in children before and during the pandemic and explores potential links to SARS-CoV-2 vaccination.
Methods:
We analyzed 493,705 anonymized medical records from Maccabi Healthcare Services, Israel's second-largest healthcare provider, to study AID incidence during 2014-2022. The study period was divided into three phases: two pre-pandemic phases of equal duration (A and B) and a pandemic phase (C).
Results:
Of 4,596 (0.9%) patients diagnosed with an AID in the cohort, incidence rates were 0.9% for Group A (2014-2016), 1.0% for Group B (2017-2019), and 0.9% for Group C (2020-2022) (p = 0.13). Logistic regression showed no significant differences in overall autoimmune disease incidence between the pre-COVID and COVID periods. Notably, specific conditions like celiac disease showed reduced incidence in Group A (OR 0.8309, p = 0.0071) while arthritis was significantly more common in Groups A and B. Additionally, COVID-19 diagnosis was not significantly associated with increased autoimmune disease risk (HR 1.092, p = 0.491); however, receiving at least one COVID vaccine was linked to higher risk (HR 1.2323, p = 0.0033).
Conclusion:
Our findings suggest that the overall incidence of new-onset autoimmune diseases in children remained relatively stable during the COVID-19 pandemic. The study indicates a potential association between COVID-19 vaccination and an increased risk of developing autoimmune diseases, necessitating further research to elucidate long-term effects in the pediatric population.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...